Peter C Fineran (Peter Fineran)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 58

Top Venues

Nucleic acids research

Nature communications

Applied and environmental microbiology

Nature

University of Otago

University of Canterbury (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Otago Feb 01 2019

New Zealand

Professor :: Department of Microbiology and Immunology

University of Otago Sep 01 2012

New Zealand

Rutherford Discovery Fellow :: Department of Microbiology and Immunology

University of Otago Feb 01 2015 - Jan 31 2019

New Zealand

Associate Professor :: Department of Microbiology and Immunology

University of Otago - Jan 31 2015

New Zealand

Senior Lecturer :: Department of Microbiology and Immunology

Wageningen Universiteit en Researchcentrum

Netherlands

Visiting Academic :: Laboratory of Microbiology

University of Otago

New Zealand

Lecturer :: Department of Microbiology and Immunology

University of Cambridge

United Kingdom

Post-doctoral Researcher :: Department of Biochemistry

Australian National University

Australia

Research Associate :: John Curtin School of Medical Research

Education History

University of Canterbury

New Zealand

BSC

University of Cambridge

United Kingdom

PHD :: Department of Biochemistry

Publications

Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Hazel M Sisson, Robert D Fagerlund, Simon A Jackson, Yves Briers, Suzanne L Warring, Peter C Fineran
Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen Pseudomonas syringae pv. actinidiae . Applied and environmental microbiology (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature 631 (8021) (2024)
David Mayo-Muñoz, Rafael Pinilla-Redondo, Sarah Camara-Wilpert, Nils Birkholz, Peter C Fineran
Inhibitors of bacterial immune systems: discovery, mechanisms and applications. Nature reviews. Genetics 25 (4) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Hazel M Sisson, Robert D Fagerlund, Simon A Jackson, Yves Briers, Suzanne L Warring, Peter C Fineran
Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen Pseudomonas syringae pv. actinidiae . Applied and environmental microbiology 90 (3) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature 631 (8021) (2024)
Hazel M Sisson, Robert D Fagerlund, Simon A Jackson, Yves Briers, Suzanne L Warring, Peter C Fineran
Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen Pseudomonas syringae pv. actinidiae . Applied and environmental microbiology 90 (3) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature (2024)
David Mayo-Muñoz, Rafael Pinilla-Redondo, Sarah Camara-Wilpert, Nils Birkholz, Peter C Fineran
Inhibitors of bacterial immune systems: discovery, mechanisms and applications. Nature reviews. Genetics (2024)
Hazel M Sisson, Robert D Fagerlund, Simon A Jackson, Yves Briers, Suzanne L Warring, Peter C Fineran
Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen Pseudomonas syringae pv. actinidiae . Applied and environmental microbiology 90 (3) (2024)
Hazel M Sisson, Robert D Fagerlund, Simon A Jackson, Yves Briers, Suzanne L Warring, Peter C Fineran
Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen Pseudomonas syringae pv. actinidiae . Applied and environmental microbiology 90 (3) (2024)
Hazel M Sisson, Robert D Fagerlund, Simon A Jackson, Yves Briers, Suzanne L Warring, Peter C Fineran
Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen Pseudomonas syringae pv. actinidiae . Applied and environmental microbiology 90 (3) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
David Mayo-Muñoz, Rafael Pinilla-Redondo, Sarah Camara-Wilpert, Nils Birkholz, Peter C Fineran
Inhibitors of bacterial immune systems: discovery, mechanisms and applications. Nature reviews. Genetics 25 (4) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature 631 (8021) (2024)
David W Taylor, Evan Schwartz, Jack Bravo, Mohd Ahsan, Luis Macias, Caitlyn McCafferty, Tyler Dangerfield, Jada N Walker, Jennifer Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund
Type III CRISPR-Cas effectors act as protein-assisted ribozymes during RNA cleavage. Research square (2023)
Benja-Min A Adler, Marena I Trinidad, Daniel Bellieny Rabelo, Elaine Zhang, Hannah M Karp, Petr Skopintsev, Brittney W Thornton, Rachel F Weissman, Peter H Yoon, Lin-Xing Chen, Tomas Hessler, Amy R Eggers, David Colognori, Ron S Boger, Erin E Doherty, Connor A Tsuchida, Ryan V Tran, Laura Hofman, Honglue Shi, Kevin M Wasko, Zehan Zhou, Chenglong Xia, Muntathar J Al-Shimary, Jaymin R Patel, Vienna C J X Thomas, Rithu Pattali, Matthew J Kan, Anna Vardapetyan, Alana Yang, Arushi Lahiri, Michaela F Maxwell, Andrew G Murdock, Glenn C Ramit, Hope R Henderson, Roland W Calvert, Rebecca S Bamert, Gavin J Knott, Audrone Lapinaite, Patrick Pausch, Joshua C Cofsky, Erik J Sontheimer, Blake Wiedenheft, Peter C Fineran, Stan J J Brouns, Dipali G Sashital, Brian C Thomas, Christopher T Brown, Daniela S A Goltsman, Rodolphe Barrangou, Virginijus Siksnys, Jillian F Banfield, David F Savage, Jennifer A Doudna
CasPEDIA Database: a functional classification system for class 2 CRISPR-Cas enzymes. Nucleic acids research (2023)
Tess M McBride, Shaharn C Cameron, Peter C Fineran, Robert D Fagerlund
The biology and type I/III hybrid nature of type I-D CRISPR-Cas systems. The Biochemical journal 480 (7) (2023)
Alfonso López-Rojo, Simon A Jackson, Diego Bernal-Bernal, Marisa Galbis-Martínez, Peter C Fineran, Montserrat Elías-Arnanz
Genome sequences of Mx1, the first Myxococcus phage isolated, and Mx4, a generalized transducing myxophage. Microbiology resource announcements (2023)
David W Taylor, Evan Schwartz, Jack Bravo, Mohd Ahsan, Luis Macias, Caitlyn McCafferty, Tyler Dangerfield, Jada N Walker, Jennifer Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund
Type III CRISPR-Cas effectors act as protein-assisted ribozymes during RNA cleavage. Research square (2023)
David W Taylor, Evan Schwartz, Jack Bravo, Mohd Ahsan, Luis Macias, Caitlyn McCafferty, Tyler Dangerfield, Jada N Walker, Jennifer Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund
Type III CRISPR-Cas effectors act as protein-assisted ribozymes during RNA cleavage. Research square (2023)
Heather L Shearer, Paul E Pace, Leah M Smith, Peter C Fineran, Allison J Matthews, Andrew Camilli, Nina Dickerhof, Mark B Hampton
Identification of Streptococcus pneumoniae genes associated with hypothiocyanous acid tolerance through genome-wide screening. Journal of bacteriology (2023)
Leah M Smith, Hannah G Hampton, Mariya S Yevstigneyeva, Marina Mahler, Zacharie S M Paquet, Peter C Fineran
CRISPR-Cas immunity is repressed by the LysR-type transcriptional regulator PigU. Nucleic acids research (2023)
Sarah Camara-Wilpert, David Mayo-Muñoz, Jakob Russel, Robert D Fagerlund, Jonas Stenløkke Madsen, Peter C Fineran, Søren Johannes Sørensen, Rafael Pinilla-Redondo
Bacteriophages suppress CRISPR-Cas immunity using RNA-based anti-CRISPRs. Nature (2023)
Suzanne L Warring, Lucia M Malone, Jay Jayaraman, Richard A Easingwood, Luciano A Rigano, Rebekah A Frampton, Sandra B Visnovsky, Shea M Addison, Loreto Hernandez, Andrew R Pitman, Elena Lopez Acedo, Torsten Kleffmann, Matthew D Templeton, Mihnea Bostina, Peter C Fineran
A lipopolysaccharide-dependent phage infects a pseudomonad phytopathogen and can evolve to evade phage resistance. Environmental microbiology 24 (10) (2022)
Saadlee Shehreen, Nils Birkholz, Peter C Fineran, Warren P Tate
Widespread repression of anti-CRISPR production by anti-CRISPR-associated proteins. Nucleic acids research 50 (15) (2022)
Leighton J Payne, Sean Meaden, Mario R Mestre, Chris Palmer, Nicolás Toro García, Peter C Fineran, Simon A Jackson
PADLOC: a web server for the identification of antiviral defence systems in microbial genomes. Nucleic acids research (2022)
Lucia M Malone, Hannah G Hampton, Xochitl C Morgan, Peter C Fineran
Type I CRISPR-Cas provides robust immunity but incomplete attenuation of phage-induced cellular stress. Nucleic acids research 50 (1) (2022)
So Yeon Lee, Nils Birkholz, Peter C Fineran, Hyun Ho Park
Molecular basis of anti-CRISPR operon repression by Aca10. Nucleic acids research 50 (15) (2022)
Evan A Schwartz, Tess M McBride, Jack P K Bravo, Daniel Wrapp, Peter C Fineran, Robert D Fagerlund, David W Taylor
Structural rearrangements allow nucleic acid discrimination by type I-D Cascade. Nature communications 13 (1) (2022)
Gi Eob Kim, So Yeon Lee, Nils Birkholz, Kotaro Kamata, Jae-Hee Jeong, Yeon-Gil Kim, Peter C Fineran, Hyun Ho Park
Molecular basis of dual anti-CRISPR and auto-regulatory functions of AcrIF24. Nucleic acids research 50 (19) (2022)
Nils Birkholz, Simon A Jackson, Robert D Fagerlund, Peter C Fineran
A mobile restriction-modification system provides phage defence and resolves an epigenetic conflict with an antagonistic endonuclease. Nucleic acids research 50 (6) (2022)
Leah M Smith, Simon A Jackson, Paul P Gardner, Peter C Fineran
SorTn-seq: a high-throughput functional genomics approach to discovering regulators of bacterial gene expression. Nature protocols 16 (9) (2021)
Leighton J Payne, Thomas C Todeschini, Yi Wu, Benjamin J Perry, Clive W Ronson, Peter C Fineran, Franklin L Nobrega, Simon A Jackson
Identification and classification of antiviral defence systems in bacteria and archaea with PADLOC reveals new system types. Nucleic acids research 49 (19) (2021)
Rafael Pinilla-Redondo, Jakob Russel, David Mayo-Muñoz, Shiraz A Shah, Roger A Garrett, Joseph Nesme, Jonas S Madsen, Peter C Fineran, Søren Johannes Sørensen
CRISPR-Cas systems are widespread accessory elements across bacterial and archaeal plasmids. Nucleic acids research (2021)
Aroa Rey Campa, Leah M Smith, Hannah G Hampton, Sahil Sharma, Simon A Jackson, Thorsten Bischler, Cynthia Mira Sharma, Peter C Fineran
The Rsm (Csr) post-transcriptional regulatory pathway coordinately controls multiple CRISPR-Cas immune systems. Nucleic acids research 49 (16) (2021)
Leah M Smith, Simon A Jackson, Lucia M Malone, James E Ussher, Paul P Gardner, Peter C Fineran
The Rcs stress response inversely controls surface and CRISPR-Cas adaptive immunity to discriminate plasmids and phages. Nature microbiology 6 (2) (2021)
Thomas L Sitter, Amy L Vaughan, Marion Schoof, Simon A Jackson, Travis R Glare, Murray P Cox, Peter C Fineran, Paul P Gardner, Mark Robin Holmes Hurst
Evolution of virulence in a novel family of transmissible mega-plasmids. Environmental microbiology 23 (9) (2021)
Simon A Jackson, Bridget J Fellows, Peter C Fineran
Complete Genome Sequences of the Escherichia coli Donor Strains ST18 and MFDpir. Microbiology resource announcements 9 (45) (2020)
Yiming Cai, Ben Usher, Claude Gutierrez, Anastasia Tolcan, Moise Mansour, Peter C Fineran, Ciarán Condon, Olivier Neyrolles, Pierre Genevaux, Tim R Blower
A nucleotidyltransferase toxin inhibits growth of Mycobacterium tuberculosis through inactivation of tRNA acceptor stems. Science advances 6 (31) (2020)
Rafael Pinilla-Redondo, Saadlee Shehreen, Nicole D Marino, Robert D Fagerlund, Warren P Tate, Søren Johannes Sørensen, Peter C Fineran, Joseph Bondy-Denomy
Discovery of multiple anti-CRISPRs highlights anti-defense gene clustering in mobile genetic elements. Nature communications 11 (1) (2020)
Jean-François Greisch, Sem Tamara, Richard A Scheltema, Howard W R Maxwell, Robert D Fagerlund, Peter C Fineran, Stephan Tetter, Donald Hilvert, Albert J R Heck
Expanding the mass range for UVPD-based native top-down mass spectrometry. Chemical science 10 (30) (2019)
Bridget N J Watson, Reuben B Vercoe, George P C Salmond, Edze Rients Westra, Raymond H J Staals, Peter C Fineran
Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity. Nature communications 10 (1) (2019)
Robert A Edwards, Alejandro A Vega, Holly M Norman, Maria Ohaeri, Kyle Levi, Elizabeth A Dinsdale, Ondrej Cinek, Ramy Karam Aziz, Katelyn McNair, Jeremy J Barr, Kyle J Bibby, Stan J J Brouns, Adrian Cazares, Patrick A de Jonge, Christelle Desnues, Samuel L Díaz Muñoz, Peter C Fineran, Alexander Kurilshikov, Rob Lavigne, Karla Mazankova, David T McCarthy, Franklin L Nobrega, Alejandro Reyes, German Tapia, Nicole Trefault, Alexander V Tyakht, Pablo Vinuesa, Jeroen Wagemans, Alexandra Zhernakova, Frank Møller Aarestrup, Gunduz Ahmadov, Abeer Alassaf, Josefa Anton, Abigail E Asangba, Emma K Billings, Vito Adrian Cantu, Jane M Carlton, Daniel Cazares, Gyu-Sung Cho, Tess Condeff, Pilar Cortés, Mike Cranfield, Daniel A Cuevas, Rodrigo De la Iglesia, Przemyslaw Decewicz, Michael P Doane, Nathaniel J Dominy, Lukasz Dziewit, Bashir Mukhtar Elwasila, A Murat Eren, Charles Franz, Jingyuan Fu, Cristina Garcia-Aljaro, Elodie Ghedin, Kristen M Gulino, John M Haggerty, Steven R Head, Rene S Hendriksen, Colin Hill, Heikki Hyöty, Elena N Ilina, Mitchell T Irwin, Thomas C Jeffries, Juan Jofre, Randall E Junge, Scott T Kelley, Mohammadali Khan Mirzaei, Martin Kowalewski, Deepak Kumaresan, Steven R Leigh, David Lipson, Eugenia S Lisitsyna, Montserrat Llagostera, Julia M Maritz, Linsey C Marr, Angela McCann, Shahar Molshanski-Mor, Silvia Monteiro, Benjamin Moreira-Grez, Megan Morris, Lawrence Mugisha, Maite Muniesa, Horst Neve, Nam-Phuong Nguyen, Olivia D Nigro, Anders S Nilsson, Taylor O'Connell, Rasha Odeh, Andrew Oliver, Mariana Piuri, Aaron J Prussin Ii, Udi Qimron, Zhe-Xue Quan, Petra Rainetova, Adán Ramírez-Rojas, Raul Raya, Kim Reasor, Gillian A O Rice, Alessandro Rossi, Ricardo J Santos, John Shimashita, Elyse N Stachler, Lars C Stene, Ronan Strain, Rebecca Stumpf, Pedro J Torres, Alan Twaddle, MaryAnn Ugochi Ibekwe, Nicolás Villagra, Stephen Wandro, Bryan White, Andy Whiteley, Katrine L Whiteson, Cisca Wijmenga, Maria M Zambrano, Henrike Zschach, Bas E Dutilh
Global phylogeography and ancient evolution of the widespread human gut virus crAssphage. Nature microbiology 4 (10) (2019)
Lucia M Malone, Suzanne L Warring, Simon A Jackson, Carolin Warnecke, Paul P Gardner, Laura F Gumy, Peter C Fineran
A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity. Nature microbiology 5 (1) (2019)
Joanna K Wojtus, Rebekah A Frampton, Suzanne Warring, Heather L Hendrickson, Peter C Fineran
Genome Sequence of a Jumbo Bacteriophage That Infects the Kiwifruit Phytopathogen Pseudomonas syringae pv. actinidiae. Microbiology resource announcements 8 (22) (2019)
Bridget N J Watson, Raymond H J Staals, Peter C Fineran
CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction. mBio 9 (1) (2018)
Ron L Dy, Luciano A Rigano, Peter C Fineran
Phage-based biocontrol strategies and their application in agriculture and aquaculture. Biochemical Society transactions 46 (6) (2018)
Thomas J Nicholson, Simon A Jackson, Bradley I Croft, Raymond H J Staals, Peter C Fineran, Warren P Tate
Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systems. RNA biology 16 (4) (2018)
Sukrit Silas, Patricia Lucas-Elio, Simon A Jackson, Alejandra Aroca-Crevillén, Loren L Hansen, Peter C Fineran, Andrew Z Fire, Antonio Sanchez-Amat
Correction: Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems. eLife 7 (2018)
Simon A Jackson, Rebecca E McKenzie, Robert D Fagerlund, Sebastian N Kieper, Peter C Fineran, Stan J J Brouns
CRISPR-Cas: Adapting to change. Science (New York, N.Y.) 356 (6333) (2017)
Sukrit Silas, Patricia Lucas-Elio, Simon A Jackson, Alejandra Aroca-Crevillén, Loren L Hansen, Peter C Fineran, Andrew Z Fire, Antonio Sanchez-Amat
Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems. eLife 6 (2017)
Tim R Blower, Ray Chai, Rita Przybilski, Shahzad Chindhy, Xinzhe Fang, Samuel E Kidman, Hui Tan, Ben F Luisi, Peter C Fineran, George P C Salmond
Evolution of Pectobacterium Bacteriophage ΦM1 To Escape Two Bifunctional Type III Toxin-Antitoxin and Abortive Infection Systems through Mutations in a Single Viral Gene. Applied and environmental microbiology 83 (8) (2017)

Peter C Fineran.css-eqlu8i{font-size:small;padding-left:4px;} (Peter Fineran)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter C Fineran (Peter Fineran)